Veru, Inc. (VERU)
2.47
-0.03
(-1.20%)
USD |
NASDAQ |
Sep 11, 13:45
Veru Gross Profit (TTM) : -0.113M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.113M |
| March 31, 2026 | -0.1143M |
| December 31, 2025 | -0.1154M |
| September 30, 2025 | -0.1521M |
| June 30, 2025 | -0.1887M |
| March 31, 2025 | -0.2244M |
| December 31, 2024 | -0.2609M |
| September 30, 2024 | -0.2682M |
| June 30, 2024 | 1.321M |
| March 31, 2024 | 2.599M |
| December 31, 2023 | 6.757M |
| September 30, 2023 | 7.531M |
| June 30, 2023 | 6.495M |
| March 31, 2023 | 12.35M |
| December 31, 2022 | 19.43M |
| September 30, 2022 | 30.57M |
| June 30, 2022 | 42.38M |
| March 31, 2022 | 49.18M |
| December 31, 2021 | 48.92M |
| September 30, 2021 | 47.85M |
| June 30, 2021 | 45.04M |
| March 31, 2021 | 37.61M |
| December 31, 2020 | 34.06M |
| September 30, 2020 | 30.47M |
| June 30, 2020 | 26.74M |
| Date | Value |
|---|---|
| March 31, 2020 | 26.80M |
| December 31, 2019 | 23.97M |
| September 30, 2019 | 21.35M |
| June 30, 2019 | 18.72M |
| March 31, 2019 | 15.23M |
| December 31, 2018 | 11.83M |
| September 30, 2018 | 8.504M |
| June 30, 2018 | 7.137M |
| March 31, 2018 | 6.383M |
| December 31, 2017 | 6.492M |
| September 30, 2017 | 6.872M |
| June 30, 2017 | 6.986M |
| March 31, 2017 | 7.965M |
| December 31, 2016 | 9.573M |
| September 30, 2016 | 13.35M |
| June 30, 2016 | 15.60M |
| March 31, 2016 | 17.00M |
| December 31, 2015 | 20.55M |
| September 30, 2015 | 18.97M |
| June 30, 2015 | 17.73M |
| March 31, 2015 | 17.27M |
| December 31, 2014 | 13.26M |
| September 30, 2014 | 13.12M |
| June 30, 2014 | 12.51M |
| March 31, 2014 | 12.08M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |
| Johnson & Johnson | 66.63B |
| Eli Lilly & Co. | 66.44B |
| Lexicon Pharmaceuticals, Inc. | 40.63M |